Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
Certolizumab Pegol
C87050
NCT00160602
Rheumatoid Arthritis
Phase 3
 
Analysis and Reporting Dataset is AD not ADaM

Datasets are available in English only
July 2014

Powered by ideaPoint, Inc.